Hexarelin vs Melanotan II

Side-by-side comparison of mechanisms, dosing, interactions, and stacking potential.

HexarelinMelanotan II
CategoryPeptidesPeptides
Standard DoseResearch indicates 100-200 mcg administered 1-2 times daily via subcutaneous injection.Research indicates 250-500 mcg daily via subcutaneous injection during loading, reducing to 250 mcg 2-3 times weekly for maintenance.
TimingOn empty stomach, bedtime preferred. Avoid prolonged continuous use due to rapid desensitization.Administer 4-6 hours before UV exposure for optimal tanning synergy. Can be taken at any time of day.
Cycle Duration4-8 week cycles maximum, then 4+ week break. Hexarelin desensitizes faster than other GHRPs.Loading phase 1-2 weeks, then maintenance as long as desired. Pigmentation fades gradually upon discontinuation.
Evidence Levelmoderate_humanmoderate_human
A

Hexarelin

Peptides

Mechanism

Hexarelin (Examorelin) is a synthetic hexapeptide GHS-R1a agonist and the most potent synthetic GH secretagogue by peak GH release. It stimulates GH release through both pituitary ghrelin receptors and hypothalamic pathways, with mechanisms involving regulation of GHRH and somatostatin. Hexarelin also demonstrates significant cardiac benefits through activation of cardiac GHS-R1a receptors, protecting against ischemia-reperfusion injury and reducing cardiac fibrosis via the CD36 scavenger receptor pathway.

Standard Dosing

Research indicates 100-200 mcg administered 1-2 times daily via subcutaneous injection.

Timing

On empty stomach, bedtime preferred. Avoid prolonged continuous use due to rapid desensitization.

Cycle Duration

4-8 week cycles maximum, then 4+ week break. Hexarelin desensitizes faster than other GHRPs.

Side Effects

  • Significant cortisol elevation
  • Prolactin increase
  • Water retention
  • Joint pain
  • Rapid desensitization (unique to Hexarelin)

Contraindications

  • Active cancer
  • Cardiac arrhythmias (due to direct cardiac receptor activity)
  • Cushing's syndrome
  • Pregnancy and breastfeeding

Best Stacking Partners

CJC-1295 (no DAC)Sermorelin
B

Melanotan II

Peptides

Mechanism

Melanotan II is a synthetic cyclic analog of alpha-melanocyte-stimulating hormone (alpha-MSH) that non-selectively agonizes melanocortin receptors MC1, MC3, MC4, and MC5. MC1R activation stimulates eumelanin synthesis through tyrosinase upregulation, producing tanning. MC3R activation in the CNS increases libido and produces erectile responses. MC4R activation suppresses appetite. The cyclic structure provides enhanced in vivo stability (half-life 1-2 hours) and increased blood-brain barrier permeability compared to linear alpha-MSH.

Standard Dosing

Research indicates 250-500 mcg daily via subcutaneous injection during loading, reducing to 250 mcg 2-3 times weekly for maintenance.

Timing

Administer 4-6 hours before UV exposure for optimal tanning synergy. Can be taken at any time of day.

Cycle Duration

Loading phase 1-2 weeks, then maintenance as long as desired. Pigmentation fades gradually upon discontinuation.

Side Effects

  • Nausea (common, especially during loading)
  • Facial flushing
  • Spontaneous erections
  • Appetite suppression
  • Darkening of existing moles (monitor closely)
  • Fatigue
  • New nevus formation

Contraindications

  • History of melanoma or atypical moles
  • Active skin cancer
  • Pregnancy and breastfeeding
  • Addison's disease
  • Pheochromocytoma

Best Stacking Partners

PT-141

Not sure which is right for you?

Take our free assessment to get personalized recommendations based on your health goals, current stack, and biomarkers.

Get Your Free Protocol →or take the assessment →